Pregled bibliografske jedinice broj: 652853
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Personalized Medicine in Neurodegenerative Diseases: How Far Away? // Molecular diagnosis & therapy, 18 (2014), 1; 17-24 doi:10.1007/s40291-013-0058-z (međunarodna recenzija, pregledni rad, znanstveni)
CROSBI ID: 652853 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Personalized Medicine in Neurodegenerative Diseases: How Far Away?
Autori
Gotovac, Kristina ; Hajnšek, Sanja ; Bošnjak Pašić, Marija ; Pivac, Nela ; Borovečki, Fran
Izvornik
Molecular diagnosis & therapy (1177-1062) 18
(2014), 1;
17-24
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, znanstveni
Ključne riječi
personalized medicine; neurodegenerative disease; genomics
Sažetak
Neurodegenerative diseases are characterized by progressive dysfunction of the nervous system as a result of neuronal loss in the brain and spinal cord. Despite extensive research efforts aimed at development of new disease-modifying therapeutics, there is still no effective treatment to halt neurodegenerative processes. Thus, modification of current therapeutic and diagnostic research strategies is a goal of increasing urgency. The biggest limitation in neurodegenerative disease research is the lack of appropriate biomarkers. Discovery of universal biomarkers capable of diagnosing patients with neurodegenerative diseases, monitoring their response to therapy, and predicting disease progression seems to be a tall order. Instead, a combination of different methodologies in the discovery of biomarkers specific for each described aspect of the disease seems to be a more viable approach. Although application of personalized medicine in diagnosis and treatment of neurodegenerative diseases may seem far off, some recent developments, such as utilizing specific biological therapies in multiple sclerosis, microRNA profiling as a source of novel biomarkers in Parkinson’s disease, or combination of neuroimaging and proteomic analyses in diagnosis of Alzheimer’s disease patients, already point to the way clinical neurology may integrate new achievements in everyday practice. Combination of genomic, proteomic, glycomic, and metabolomic approaches may yield novel insights into molecular mechanisms of disease pathophysiology, which could then be integrated and translated into clinical neurology. Based on the developments during the past decade, it is feasible to predict that a personalized approach to treating neurological disorders will become more widely applicable in the coming years.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Sanja Propadalo-Hajnšek
(autor)
Kristina Gotovac Jerčić
(autor)
Fran Borovečki
(autor)
Nela Pivac
(autor)
Marija Bošnjak-Pašić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- Education Research Abstracts Online